---
figid: PMC9935929__41392_2023_1331_Fig5_HTML
figtitle: 'Signaling pathways in rheumatoid arthritis: implications for targeted therapy'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9935929
filename: 41392_2023_1331_Fig5_HTML.jpg
figlink: /pmc/articles/PMC9935929/figure/Fig5/
number: F5
caption: Main signaling pathways and their inhibitors related to RA. The JAK signaling
  pathway, Notch signaling pathway, MAPK signaling pathway, Wnt signaling pathway,
  PI3K signaling pathway, and SYK signaling pathway are the main signaling pathways
  involved in the process of RA. Related signalings are often the potential targets
  for drug discovery
papertitle: 'Signaling pathways in rheumatoid arthritis: implications for targeted
  therapy.'
reftext: Qian Ding, et al. Signal Transduct Target Ther. 2023;8:68.
year: '2023'
doi: 10.1038/s41392-023-01331-9
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group UK
keywords: Rheumatic diseases | Drug discovery
automl_pathway: 0.9257374
figid_alias: PMC9935929__F5
figtype: Figure
redirect_from: /figures/PMC9935929__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9935929__41392_2023_1331_Fig5_HTML.html
  '@type': Dataset
  description: Main signaling pathways and their inhibitors related to RA. The JAK
    signaling pathway, Notch signaling pathway, MAPK signaling pathway, Wnt signaling
    pathway, PI3K signaling pathway, and SYK signaling pathway are the main signaling
    pathways involved in the process of RA. Related signalings are often the potential
    targets for drug discovery
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PSMB6
  - YY1
  - DLL1
  - SYK
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ADAR
  - DVL1P1
  - RAC1
  - RNASE1
  - MAP3K1
  - MAP3K2
  - MAP3K3
  - MAP3K4
  - MAP3K5
  - MAP3K6
  - MAP3K7
  - MAP3K8
  - MAP3K9
  - MAP3K10
  - MAP3K11
  - MAP3K12
  - MAP3K13
  - MAP3K14
  - MAP3K15
  - MAP3K19
  - MAP3K20
  - MAP3K21
  - ARAF
  - BRAF
  - RAF1
  - TAOK1
  - TAOK2
  - TAOK3
  - NAV2
  - AKT1
  - AKT2
  - AKT3
  - BTK
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MTOR
  - GSK3B
  - MAP2K3
  - MAP2K4
  - MAP2K5
  - MAP2K6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - EPHB2
  - HIF1A
  - CTNNB1
  - JUN
  - ATF2
  - GDNF
  - NFKB1
  - FOS
  - Dsh
  - Nucleus
  - inhibitors
  - inhibitor
  - Baricitinib
  - Tofacitinib
---
